Article Type
Changed
Tue, 12/11/2018 - 15:02
Display Headline
The use of aripiprazole in the management of bipolar disorder during pregnancy

"This patient had presented 2-weeks postpartum in a manic state with psycotic features. She was screened by Ob-Gyn who collaborated with her care while she was admitted to the psychiatric inpatient unit. Patient had been non-compliant with prescribed medications prior to admission and she was started on aripiprazole from day one and the dose was tapered up to 15 mg BID by day 5. Patient's manic symptoms improved slowly as the days progressed by day 8 psychotic symptoms started to subside. As delivery was imminent, patient was transferred to Ob-Gyn service. She delivered a healthy but premature child via csection on day 12. Child did not exhibit any gross or anatomic malformations. She was continued on aripiprazole 15 mg BID after discharge and was seen weeks later in outpatient psychiatry."

Read more from the Poster Abstracts from the 2015 APA Annual Meeting

References

Author and Disclosure Information

Julian F. DeSouza, MD

Publications
Topics
Legacy Keywords
bipolar disorder, pregnancy, women's health, bipolar, mood disorders, mood disorder, pregnant, aripiprazole
Sections
Author and Disclosure Information

Julian F. DeSouza, MD

Author and Disclosure Information

Julian F. DeSouza, MD

"This patient had presented 2-weeks postpartum in a manic state with psycotic features. She was screened by Ob-Gyn who collaborated with her care while she was admitted to the psychiatric inpatient unit. Patient had been non-compliant with prescribed medications prior to admission and she was started on aripiprazole from day one and the dose was tapered up to 15 mg BID by day 5. Patient's manic symptoms improved slowly as the days progressed by day 8 psychotic symptoms started to subside. As delivery was imminent, patient was transferred to Ob-Gyn service. She delivered a healthy but premature child via csection on day 12. Child did not exhibit any gross or anatomic malformations. She was continued on aripiprazole 15 mg BID after discharge and was seen weeks later in outpatient psychiatry."

Read more from the Poster Abstracts from the 2015 APA Annual Meeting

"This patient had presented 2-weeks postpartum in a manic state with psycotic features. She was screened by Ob-Gyn who collaborated with her care while she was admitted to the psychiatric inpatient unit. Patient had been non-compliant with prescribed medications prior to admission and she was started on aripiprazole from day one and the dose was tapered up to 15 mg BID by day 5. Patient's manic symptoms improved slowly as the days progressed by day 8 psychotic symptoms started to subside. As delivery was imminent, patient was transferred to Ob-Gyn service. She delivered a healthy but premature child via csection on day 12. Child did not exhibit any gross or anatomic malformations. She was continued on aripiprazole 15 mg BID after discharge and was seen weeks later in outpatient psychiatry."

Read more from the Poster Abstracts from the 2015 APA Annual Meeting

References

References

Publications
Publications
Topics
Article Type
Display Headline
The use of aripiprazole in the management of bipolar disorder during pregnancy
Display Headline
The use of aripiprazole in the management of bipolar disorder during pregnancy
Legacy Keywords
bipolar disorder, pregnancy, women's health, bipolar, mood disorders, mood disorder, pregnant, aripiprazole
Legacy Keywords
bipolar disorder, pregnancy, women's health, bipolar, mood disorders, mood disorder, pregnant, aripiprazole
Sections
Article Source

PURLs Copyright

Inside the Article